Subarachnoid-Subarachnoid (S-S) Bypass Versus Adhesion Lysis in Spinal Arachnoiditis and Syringomyelia

Launched by XUANWU HOSPITAL, BEIJING · Apr 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical treatments for people with a condition called Syringomyelia, which is often linked to issues like spinal cord injuries or infections. The trial will compare a procedure called Subarachnoid-Subarachnoid (S-S) Bypass with another procedure known as adhesion lysis. The goal is to see if the S-S Bypass leads to better results, with fewer complications and an improved quality of life for patients.

To participate in this trial, individuals should be between 18 and 75 years old and have a history of spinal cord injury or infection, along with certain symptoms such as ongoing pain or worsening neurological issues. An MRI must show the presence of Syringomyelia related to their injury or infection. Participants can expect regular follow-ups for more than a year to monitor their progress. It's important to know that individuals with certain other conditions, like Chiari malformation or myelomalacia, won't be eligible for this study. If you or a loved one fits the criteria, this trial could offer a chance to explore new treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) history of traumatic spinal cord injury or other infection; 2) evidence of progressive neurological deficit, and/or pain syndrome; 3) MRI showing a syringomyelia due to spinal trauma or other infection; and 4) minimum follow-up period of more than 1 year.
• Exclusion Criteria:
• • Chiari-malformation, myelomalacia, subarachnoid cyst, syringomyelia due to other spinal diseases (such as degenerative spinal disease)